These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9839563)

  • 1. Bacterial translocation, intestinal microflora and morphological changes of intestinal mucosa in experimental models of Clostridium difficile infection.
    Naaber P; Mikelsaar RH; Salminen S; Mikelsaar M
    J Med Microbiol; 1998 Jul; 47(7):591-8. PubMed ID: 9839563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effect of a mixture of kefir-isolated lactic acid bacteria and yeasts in a hamster model of Clostridium difficile infection.
    Bolla PA; Carasi P; Bolla Mde L; De Antoni GL; Serradell Mde L
    Anaerobe; 2013 Jun; 21():28-33. PubMed ID: 23542116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A combination of the probiotic and prebiotic product can prevent the germination of Clostridium difficile spores and infection.
    Rätsep M; Kõljalg S; Sepp E; Smidt I; Truusalu K; Songisepp E; Stsepetova J; Naaber P; Mikelsaar RH; Mikelsaar M
    Anaerobe; 2017 Oct; 47():94-103. PubMed ID: 28465256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of biotherapeutics on cyclosporin-induced Clostridium difficile infection in mice.
    Kaur S; Vaishnavi C; Ray P; Kochhar R; Prasad KK
    J Gastroenterol Hepatol; 2010 Apr; 25(4):832-8. PubMed ID: 20074161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clostridium difficile--a spectrum of virulence and analysis of putative virulence determinants in the hamster model of antibiotic-associated colitis.
    Borriello SP; Ketley JM; Mitchell TJ; Barclay FE; Welch AR; Price AB; Stephen J
    J Med Microbiol; 1987 Aug; 24(1):53-64. PubMed ID: 3612744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clostridium difficile typhlitis associated with cecal mucosal hyperplasia in Syrian hamsters.
    Ryden EB; Lipman NS; Taylor NS; Rose R; Fox JG
    Lab Anim Sci; 1991 Dec; 41(6):553-8. PubMed ID: 1667196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of Gr-1(+) cells and tumour necrosis factor-α signalling during Clostridium difficile colitis in mice.
    McDermott AJ; Higdon KE; Muraglia R; Erb-Downward JR; Falkowski NR; McDonald RA; Young VB; Huffnagle GB
    Immunology; 2015 Apr; 144(4):704-16. PubMed ID: 25399934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of the intestinal microbiome: fecal microbiota transplant and probiotics for Clostridium difficile and beyond.
    Vindigni SM; Broussard EK; Surawicz CM
    Expert Rev Gastroenterol Hepatol; 2013 Sep; 7(7):615-28. PubMed ID: 24070153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of adhesion of Clostridium difficile to Caco-2 cells.
    Naaber P; Lehto E; Salminen S; Mikelsaar M
    FEMS Immunol Med Microbiol; 1996 Jul; 14(4):205-9. PubMed ID: 8856319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clostridium difficile toxins and enterococcal translocation in vivo and in vitro.
    Feltis BA; Garni RM; Wells CL
    J Surg Res; 2001 May; 97(1):97-102. PubMed ID: 11319888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New approach to the management of Clostridium difficile infection: colonisation with non-toxigenic C. difficile during daily ampicillin or ceftriaxone administration.
    Merrigan MM; Sambol SP; Johnson S; Gerding DN
    Int J Antimicrob Agents; 2009 Mar; 33 Suppl 1():S46-50. PubMed ID: 19303570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of bacterial metabolism and physiology in the pathogenesis of Clostridium difficile disease.
    Bongaerts GP; Lyerly DM
    Microb Pathog; 1997 Apr; 22(4):253-6. PubMed ID: 9140922
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention of Clostridium difficile-induced experimental pseudomembranous colitis by Saccharomyces boulardii: a scanning electron microscopic and microbiological study.
    Castex F; Corthier G; Jouvert S; Elmer GW; Lucas F; Bastide M
    J Gen Microbiol; 1990 Jun; 136(6):1085-9. PubMed ID: 2200843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of bifidobacteria in an experimental model of Clostridium difficile associated colitis.
    Trejo FM; De Antoni GL; Pérez PF
    J Dairy Res; 2013 Aug; 80(3):263-9. PubMed ID: 23611644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemically administered IgG anti-toxin antibodies protect the colonic mucosa during infection with Clostridium difficile in the piglet model.
    Cohen OR; Steele JA; Zhang Q; Schmidt DJ; Wang Y; Hamel PE; Beamer G; Xu B; Tzipori S
    PLoS One; 2014; 9(10):e111075. PubMed ID: 25347821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Passive immunisation of hamsters against Clostridium difficile infection using antibodies to surface layer proteins.
    O'Brien JB; McCabe MS; Athié-Morales V; McDonald GS; Ní Eidhin DB; Kelleher DP
    FEMS Microbiol Lett; 2005 May; 246(2):199-205. PubMed ID: 15899406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the Adherence of
    Mora-Uribe P; Miranda-Cárdenas C; Castro-Córdova P; Gil F; Calderón I; Fuentes JA; Rodas PI; Banawas S; Sarker MR; Paredes-Sabja D
    Front Cell Infect Microbiol; 2016; 6():99. PubMed ID: 27713865
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibiotic treatment with ampicillin accelerates the healing of colonic damage impaired by aspirin and coxib in the experimental colitis. Importance of intestinal bacteria, colonic microcirculation and proinflammatory cytokines.
    Zwolinska-Wcislo M; Krzysiek-Maczka G; Ptak-Belowska A; Karczewska E; Pajdo R; Sliwowski Z; Urbanczyk K; Drozdowicz D; Konturek SJ; Pawlik WW; Brzozowski T
    J Physiol Pharmacol; 2011 Jun; 62(3):357-68. PubMed ID: 21893697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of probiotics in the prevention and treatment of antibiotic-associated diarrhea with special interest in Clostridium difficile-associated diarrhea.
    Rohde CL; Bartolini V; Jones N
    Nutr Clin Pract; 2009; 24(1):33-40. PubMed ID: 19244146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleotide-binding oligomerization domain 1 mediates recognition of Clostridium difficile and induces neutrophil recruitment and protection against the pathogen.
    Hasegawa M; Yamazaki T; Kamada N; Tawaratsumida K; Kim YG; Núñez G; Inohara N
    J Immunol; 2011 Apr; 186(8):4872-80. PubMed ID: 21411735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.